Chandra Bhagat Pharma Limited
BSE: CBPL
Prev Close
58
Open Price
58
Volume
2,000
Today Low / High
57.95 / 58
52 WK Low / High
46.15 / 80
Range
55 - 61
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 57.95, reflecting a change of -0.05 (-0.0862069%). The expected target range on the BSE is 55 - 61. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Chandra Bhagat Pharma Limited Graph
Chandra Bhagat Pharma Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Chandra Bhagat Pharma Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 57.95, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 57.95 | 58.53 | 52.68 - 64.38 |
| 59.11 | 47.29 - 70.93 | ||
| 59.69 | 41.78 - 77.60 | ||
| Bearish Scenario | 57.95 | 57.37 | 51.63 - 63.11 |
| 56.79 | 45.43 - 68.15 | ||
| 56.21 | 39.35 - 73.07 |
Overview of Chandra Bhagat Pharma Limited
ISIN
INE07QQ01016
Industry
Medical - Distribution
Vol.Avg
6,916
Market Cap
437,236,227
Last Dividend
0
Official Website
IPO Date
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 86.72 Cr | 73.28 Cr | 13.44 Cr | 0.1549 | 0.00 Cr | 0.00 Cr | -2.41 Cr | 0.86 Cr | 1.14 | 4.06 Cr | 0.0099 |
| 2024-03-31 | 222.50 Cr | 208.27 Cr | 14.23 Cr | 0.0640 | 0.07 Cr | 2.72 Cr | 11.19 Cr | 1.53 Cr | 2.03 | 4.29 Cr | 0.0069 |
| 2023-03-31 | 119.67 Cr | 106.77 Cr | 12.90 Cr | 0.1078 | 0.07 Cr | 1.87 Cr | 3.95 Cr | 0.91 Cr | 1.20 | 3.45 Cr | 0.0076 |
| 2022-03-31 | 94.21 Cr | 81.44 Cr | 12.63 Cr | 0.1341 | 0.00 Cr | 1.80 Cr | 5.40 Cr | 0.80 Cr | 1.06 | 4.12 Cr | 0.0085 |
| 2021-03-31 | 70.70 Cr | 59.83 Cr | 10.87 Cr | 0.1537 | 0.00 Cr | 2.09 Cr | 4.03 Cr | 0.19 Cr | 0.25 | 3.87 Cr | 0.0027 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.67 Cr | 101.53 Cr | 71.56 Cr | 29.9691 Cr | 20.86 Cr | 20.19 Cr | 0.69 Cr | 2.62 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 69.2490 Cr |
| 2024-03-31 | 4.96 Cr | 101.80 Cr | 72.80 Cr | 29.0090 Cr | 16.43 Cr | 11.46 Cr | 8.68 Cr | 2.52 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 71.0598 Cr |
| 2023-03-31 | 6.44 Cr | 60.58 Cr | 33.10 Cr | 27.4787 Cr | 18.94 Cr | 12.51 Cr | 29.08 Cr | 0.73 Cr | 0.90 Cr | 0.00 Cr | 0.00 Cr | 26.9477 Cr |
| 2022-03-31 | 5.68 Cr | 72.46 Cr | 45.79 Cr | 26.6755 Cr | 21.12 Cr | 15.44 Cr | 34.16 Cr | 0.47 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 38.0517 Cr |
| 2021-03-31 | 2.82 Cr | 71.78 Cr | 45.90 Cr | 25.8788 Cr | 27.07 Cr | 24.25 Cr | 35.14 Cr | 0.42 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 32.8711 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -5.7088 Cr | -0.7821 Cr | 2.1918 Cr | -6.9113 Cr | -4.2991 Cr | 0.6651 Cr | -1.2025 Cr | 1.1654 Cr | 4.1396 Cr | 0.0000 Cr | 7.9847 Cr |
| 2024-03-31 | 6.1756 Cr | -1.8526 Cr | -5.7982 Cr | 3.8939 Cr | -1.4753 Cr | 4.9642 Cr | -2.2817 Cr | 1.5303 Cr | -4.4074 Cr | 0.0000 Cr | 20.4008 Cr |
| 2023-03-31 | 5.2642 Cr | -0.0590 Cr | -4.4469 Cr | 4.8957 Cr | 0.7582 Cr | 6.4395 Cr | -0.3685 Cr | 0.9054 Cr | -1.5799 Cr | 0.0000 Cr | 5.0791 Cr |
| 2022-03-31 | 12.3984 Cr | 0.0854 Cr | -9.6236 Cr | 12.2986 Cr | 2.8601 Cr | 5.6813 Cr | -0.0998 Cr | 0.7967 Cr | -5.2986 Cr | 0.0000 Cr | 0.9827 Cr |
| 2021-03-31 | 8.3287 Cr | 0.1185 Cr | -6.4241 Cr | 8.3084 Cr | 2.0231 Cr | 2.8212 Cr | -0.0203 Cr | 0.1899 Cr | -1.9571 Cr | 0.0000 Cr | 8.7634 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 32.46 Cr | 27.84 Cr | 4.62 Cr | 0.1423 | 4.02 Cr | 0.34 Cr | 0.46 | 0.94 Cr | 0.0106 |
| 2024-06-30 | 32.46 Cr | 27.84 Cr | 4.62 Cr | 0.1423 | 4.02 Cr | 0.34 Cr | 0.46 | 0.94 Cr | 0.0106 |
| 2024-03-31 | 51.62 Cr | 45.38 Cr | 6.24 Cr | 0.1208 | 5.23 Cr | 0.45 Cr | 0.59 | 0.96 Cr | 0.0087 |
| 2023-12-31 | 51.62 Cr | 45.38 Cr | 6.24 Cr | 0.1208 | 5.23 Cr | 0.45 Cr | 0.59 | 0.96 Cr | 0.0087 |
| 2023-09-30 | 59.63 Cr | 58.75 Cr | 0.88 Cr | 0.0147 | 0.79 Cr | 0.32 Cr | 0.42 | 0.86 Cr | 0.0053 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.67 Cr | 0.14 Cr | 0.80 Cr | 94.85 Cr | 0.69 Cr | 97.45 Cr | 2.62 Cr | 101.53 Cr | 71.56 Cr |
| 2024-09-30 | 2.38 Cr | 0.55 Cr | 2.92 Cr | 86.49 Cr | 0.37 Cr | 90.11 Cr | 2.11 Cr | 94.53 Cr | 64.84 Cr |
| 2024-06-30 | 2.38 Cr | 0.55 Cr | 2.92 Cr | 49.16 Cr | 0.37 Cr | 90.11 Cr | 2.11 Cr | 94.53 Cr | 64.84 Cr |
| 2024-03-31 | 4.96 Cr | 0.13 Cr | 5.10 Cr | 53.28 Cr | 8.68 Cr | 97.92 Cr | 2.52 Cr | 101.80 Cr | 72.80 Cr |
| 2023-12-31 | 4.96 Cr | 0.13 Cr | 5.10 Cr | 39.45 Cr | 8.68 Cr | 97.92 Cr | 2.52 Cr | 101.80 Cr | 72.80 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 0.34 Cr | -3.64 Cr | -0.33 Cr | 2.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -0.13 Cr | -3.64 Cr |
| 2024-06-30 | 0.34 Cr | -3.64 Cr | -0.33 Cr | 2.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -0.13 Cr | -3.64 Cr |
| 2024-03-31 | 0.45 Cr | 3.79 Cr | -0.10 Cr | -1.63 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -0.63 Cr | 3.16 Cr |
| 2023-12-31 | 0.45 Cr | 3.79 Cr | -0.10 Cr | -1.63 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -0.63 Cr | 3.16 Cr |
| 2023-09-30 | 0.32 Cr | -0.71 Cr | -0.82 Cr | -1.27 Cr | -2.80 Cr | -2.80 Cr | 0.00 Cr | -0.51 Cr | -1.21 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Distribution
No stocks found in this industry.
Key Executives
Gender: female
Year Born: 1985
Gender: male
Year Born: 1985
Gender: female
Year Born:
Gender: male
Year Born: 1961
FAQs about Chandra Bhagat Pharma Limited
The CEO is Hemant Chandravadan Bhagat.
The current price is ₹57.95.
The range is ₹46.15-80.
The market capitalization is ₹43.72 crores.
The P/E ratio is 27.60.
The company operates in the Healthcare sector.
Overview of Chandra Bhagat Pharma Limited (ISIN: INE07QQ01016) is a leading Medical - Distribution in India. With a market capitalization of ₹43.72 crores and an average daily volume of 6,916 shares, it operates in the Medical - Distribution. The company last declared a dividend of ₹0.